CY1107107T1 - Σουλφοναμιδικα παραγωγα για την αγωγη νοσων - Google Patents

Σουλφοναμιδικα παραγωγα για την αγωγη νοσων

Info

Publication number
CY1107107T1
CY1107107T1 CY20071101628T CY071101628T CY1107107T1 CY 1107107 T1 CY1107107 T1 CY 1107107T1 CY 20071101628 T CY20071101628 T CY 20071101628T CY 071101628 T CY071101628 T CY 071101628T CY 1107107 T1 CY1107107 T1 CY 1107107T1
Authority
CY
Cyprus
Prior art keywords
disease
sulfonamid
products
disorders
conditions
Prior art date
Application number
CY20071101628T
Other languages
English (en)
Inventor
Alan D Brown
Mark E Bunnage
Paul A Glossop
Kim James
Charlotte Al Lane
Russell A Lewthwaite
Ian B Moses
David A Price
Nicholas M Thomson
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34890770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107107(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0406387A external-priority patent/GB0406387D0/en
Priority claimed from EP05702252A external-priority patent/EP1708991B1/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of CY1107107T1 publication Critical patent/CY1107107T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση αναφέρεται σε ενώσεις του τύπου (1) και διεργασίες για την παραγωγή τους, συνθέσεις που τις περιέχουν και χρήσεις τέτοιων παραγώγων. Οι ενώσεις σύμφωνα με την παρούσα εφεύρεση είναι χρήσιμες για πολλές νόσους, διαταραχές και καταστάσεις, και ιδιαίτερα, φλεγμονώδεις, αλλεργικές και αναπνευστικές νόσους, διαταραχές και καταστάσεις.
CY20071101628T 2004-01-22 2007-12-20 Σουλφοναμιδικα παραγωγα για την αγωγη νοσων CY1107107T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290169 2004-01-22
GB0406387A GB0406387D0 (en) 2004-03-22 2004-03-22 Sulfonamide derivatives for the treatment of diseases
US60026004P 2004-08-09 2004-08-09
EP05702252A EP1708991B1 (en) 2004-01-22 2005-01-12 Sulfonamide derivatives for the treatment of diseases

Publications (1)

Publication Number Publication Date
CY1107107T1 true CY1107107T1 (el) 2012-10-24

Family

ID=34890770

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101628T CY1107107T1 (el) 2004-01-22 2007-12-20 Σουλφοναμιδικα παραγωγα για την αγωγη νοσων

Country Status (7)

Country Link
CR (1) CR9838A (el)
CY (1) CY1107107T1 (el)
EC (1) ECSP066700A (el)
HK (1) HK1096379A1 (el)
HR (1) HRP20070542T3 (el)
IL (1) IL176564A (el)
MA (1) MA28302A1 (el)

Also Published As

Publication number Publication date
CR9838A (es) 2008-04-21
MA28302A1 (fr) 2006-11-01
IL176564A0 (en) 2006-10-31
IL176564A (en) 2011-11-30
ECSP066700A (es) 2006-10-31
HRP20070542T3 (en) 2008-02-29
HK1096379A1 (en) 2007-06-01

Similar Documents

Publication Publication Date Title
CY1106894T1 (el) Παραγωγα σουλφοναμιδιων για την αγωγη ασθενειων
EA200870282A1 (ru) Производные амина
EA200601868A1 (ru) 3- или 4-монозамещённые производные фенола и тиофенола, полезные в качестве н-лигандов
EA200601462A1 (ru) Соединения для лечения заболеваний
CY1113105T1 (el) Παραγωγα ξανθινης, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
EA200601223A1 (ru) Производные сульфонамида для лечения заболеваний
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
CY1111757T1 (el) Παραγωγα ξανθινης ως εκλεκτικοι αναστολεις ημ74α
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
CY1111166T1 (el) Νεα παραγωγα 1,4-βενζοθειεπινο-1,1-διοξειδιου υποκατεστημενα με ριζες βενζυλιου, μεθοδοι διεργασιων για την παρασκευη τους, φαρμακα που περιεχουν αυτες τις ενωσεις και η χρηση τους
UY28339A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
NO20051406L (no) Indolderivater som beta-2 agonister
CY1113617T1 (el) Νεα παραγωγα φαινυλαμινοπυριμιδινης ως αναστολεις της κινασης bcr-abl
IS8062A (is) 2,4-dí(fenýlamínó)pýrimídín sem eru gagnleg í meðhöndlun æxlissjúkdóma, bólgusjúkdóma og ónæmiskerfissjúkdóma
SE0303180D0 (sv) Novel compounds
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
SE0302232D0 (sv) Novel Compounds
CY1108752T1 (el) Παραγωγα πουρινης δρωντα ως αγωνιστες του α2α-υποδοχεα
CY1107429T1 (el) Υποκατεστημενες ν-κυκλοεξυλιμιδαζολινονες με τροποποιητικη δραση επι της mch
CY1113257T1 (el) Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων
UY28317A1 (es) Compuestos útiles para el tratamiento de enfermedades
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
BRPI0508927A (pt) compostos úteis para o tratamento de doenças
CY1107101T1 (el) Μεθοδος συνθεσης παραγωγων της 1,3-διϋδρο-2h-3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης με φαρμακευτικως αποδεκτο οξυ